sing brain imaging to evaluate the effects of anxiety medication in patients with social anxiety disorder

Not Applicable

Completed

• Conditions: Social anxiety disorder (social phobia); Mental and Behavioural Disorders; Social anxiety disorder

• Registration Number: ISRCTN98890605
• Lead Sponsor: ppsala University (Sweden)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-03-17
• Last Update Posted: 20 November 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

1. Social anxiety disorder (social phobia), according to DSM-5, must be the main diagnosis as assessed with the structured clinical interview for DSM disorders (SCID)
2. Otherwise somatically healthy
3. Age 18-65, but not postmenopausal
4. Willingness to participate in a symptom provocation brain imaging trial

Exclusion Criteria

1. Treatment of social anxiety within the three months preceding the study
2. Current serious or dominant psychiatric disorder other than social anxiety disorder (e.g. psychosis, major depressive disorder, bipolar disorder)
3. Suicidal ideation
4. Chronic use of prescribed medication that could influence the results (e.g. other anxiolytic or antidepressant drugs, certain hypnotics or herbs like St John?s Wort)
5. Abuse of alcohol or narcotics
6. Pregnancy or planned pregnancy during the study period
7. Menopause
8. Previous positron emission tomography (PET) examination
9. Contraindications for MRI investigation (e.g. implants or other metal objects in the body, brain and heart operations)

Study & Design

• Study Type: Interventional
• Study Design: Not specified